Sharescart Research Club logo

Natraj Proteins Overview

Natraj Proteins Ltd. is an Indian agro-processing company engaged in the extraction, processing, and trading of edible oils and oilseed-based products. The company primarily deals in products such as soybean oil, refined edible oils, and oil cakes, which are used for both human consumption and as animal feed. Its operations are closely linked to the agricultural sector, making performance sensitive to factors such as oilseed availability, crop yields, monsoon conditions, and fluctuations in raw material prices. Natraj Proteins operates in a com...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Natraj Proteins Key Financials

Market Cap ₹14 Cr.

Stock P/E -9.6

P/B 0.4

Current Price ₹37.5

Book Value ₹ 86

Face Value 10

52W High ₹47.9

Dividend Yield 0%

52W Low ₹ 28

Natraj Proteins Share Price

₹ | |

Volume
Price

Natraj Proteins Quarterly Price

Show Value Show %

Natraj Proteins Peer Comparison

Natraj Proteins Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 36 78 39 39 23 33 23 27 27 29
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 36 78 39 39 23 33 23 27 27 29
Total Expenditure 41 79 37 40 23 33 21 27 28 25
Operating Profit -5 -1 2 -1 -0 1 2 -1 -1 4
Interest 1 1 1 1 1 1 1 1 1 1
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -6 -2 1 -2 -1 0 1 -1 -2 3
Provision for Tax 0 0 0 -0 0 0 0 0 0 0
Profit After Tax -6 -2 1 -2 -1 0 1 -1 -2 3
Adjustments -0 -0 0 0 0 0 0 0 0 0
Profit After Adjustments -6 -2 1 -2 -1 0 1 -1 -2 3
Adjusted Earnings Per Share -15 -4.7 2.7 -4.6 -2.7 0.1 3.4 -3.2 -4.4 7.7

Natraj Proteins Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 302 201 258 194 191 154 146 145 144 194 118 106
Other Income 1 1 1 0 0 0 0 0 0 0 0 0
Total Income 303 201 259 195 191 154 146 145 144 194 118 106
Total Expenditure 296 202 254 188 185 150 143 131 141 203 117 101
Operating Profit 7 -1 5 7 6 5 3 14 3 -9 2 4
Interest 5 3 4 4 4 4 2 1 2 3 2 4
Depreciation 1 1 1 1 1 1 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 -5 0 2 1 0 1 13 1 -12 -1 1
Provision for Tax 0 -0 0 0 0 -0 1 4 0 0 0 0
Profit After Tax 2 -5 0 2 1 0 0 9 1 -13 -1 1
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 2 -5 0 2 1 0 0 9 1 -13 -1 1
Adjusted Earnings Per Share 4.1 -14.2 0.6 4.3 3.1 0.9 1.1 25 1.9 -33.4 -3.9 3.5

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -39% -7% -5% -9%
Operating Profit CAGR 0% -48% -17% -12%
PAT CAGR 0% NAN% 0% NAN%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -8% -11% 6% 2%
ROE Average -4% -11% -2% -1%
ROCE Average 2% -2% 4% 5%

Natraj Proteins Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 38 33 33 34 35 36 36 45 46 34 32
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 1 0 0 0 0 0 0 3 3 1 1
Other Non-Current Liabilities 1 1 1 1 1 1 1 1 1 1 1
Total Current Liabilities 56 37 32 71 36 34 31 26 40 42 25
Total Liabilities 95 71 65 106 73 71 68 76 89 78 59
Fixed Assets 6 5 4 4 4 3 3 4 4 5 5
Other Non-Current Assets 8 5 7 5 3 2 5 8 10 9 11
Total Current Assets 81 61 54 98 66 65 61 64 75 63 43
Total Assets 95 71 65 106 73 71 68 76 89 78 59

Natraj Proteins Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 10 20 6 3 0 4 2 0 5 2 1
Cash Flow from Operating Activities 25 9 3 -37 30 2 9 6 3 -6 22
Cash Flow from Investing Activities -2 4 -2 3 2 0 -0 -3 -3 0 -2
Cash Flow from Financing Activities -13 -27 -4 31 -28 -4 -10 2 -2 3 -20
Net Cash Inflow / Outflow 10 -14 -3 -3 4 -2 -2 5 -2 -2 -1
Closing Cash & Cash Equivalent 20 6 3 0 4 2 0 5 2 1 0

Natraj Proteins Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.05 -14.18 0.61 4.29 3.06 0.9 1.05 24.99 1.9 -33.41 -3.9
CEPS(Rs) 5.9 -12.21 2.3 5.88 4.8 2.59 2.12 26.04 3.04 -32.22 -2.98
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 101.14 86.88 87.24 91.56 94.43 95.11 96.26 121.32 123.39 89.96 86.01
Core EBITDA Margin(%) 1.97 -0.88 1.53 3.29 3.15 2.93 2.11 9.79 2.08 -4.83 0.95
EBIT Margin(%) 2.06 -0.96 1.5 3.1 2.92 2.55 1.91 9.69 1.93 -4.91 1.07
Pre Tax Margin(%) 0.56 -2.65 0.12 0.91 0.71 0.21 0.67 8.95 0.71 -6.43 -1
PAT Margin (%) 0.5 -2.64 0.09 0.82 0.6 0.22 0.27 6.47 0.5 -6.46 -1.24
Cash Profit Margin (%) 0.73 -2.28 0.33 1.13 0.94 0.63 0.54 6.74 0.79 -6.23 -0.95
ROA(%) 1.56 -6.39 0.33 1.87 1.28 0.47 0.56 12.98 0.86 -14.98 -2.14
ROE(%) 4.01 -15.09 0.7 4.79 3.29 0.95 1.1 22.97 1.55 -31.32 -4.44
ROCE(%) 7.33 -2.91 7.49 8.65 7.19 5.93 4.47 21.43 3.64 -12.38 1.96
Receivable days 12.61 17.4 11.77 23.71 32.7 44.63 40.63 40.26 37.52 27.59 40.11
Inventory Days 66.66 80.45 56.82 109.36 117.24 98.66 108.95 107.21 122 94.75 119.83
Payable days 10.38 22.81 17.8 27.32 20.16 7.7 12.92 12.55 10.33 7.79 4.95
PER(x) 10.38 0 52.84 6.85 8.79 24.44 26.38 4.21 20.31 0 0
Price/Book(x) 0.42 0.3 0.37 0.32 0.28 0.23 0.29 0.87 0.31 0.43 0.43
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.13 0.11 0.11 0.33 0.19 0.24 0.22 0.43 0.32 0.28 0.31
EV/Core EBITDA(x) 5.61 -19.28 6.07 9.73 5.93 8.06 10.13 4.29 14.29 -5.95 22.8
Net Sales Growth(%) -17.03 -33.52 28.86 -24.78 -1.9 -19.18 -5.13 -1.03 -0.77 34.91 -39.2
EBIT Growth(%) -58.32 -131.13 300.56 56.22 -8.18 -29.24 -29.14 403.09 -80.2 -442.59 113.22
PAT Growth(%) -81.28 -450.11 104.28 606.37 -28.59 -70.44 16.12 2279.21 -92.39 -1856.07 88.32
EPS Growth(%) -81.28 -450.11 104.28 606.41 -28.59 -70.44 16.12 2279.16 -92.39 -1856.05 88.32
Debt/Equity(x) 1.13 0.6 0.58 1.58 0.87 0.87 0.61 0.6 0.73 1.19 0.7
Current Ratio(x) 1.46 1.65 1.71 1.38 1.84 1.91 1.94 2.42 1.89 1.51 1.72
Quick Ratio(x) 0.67 0.44 0.57 0.23 0.7 0.68 0.51 0.91 0.48 0.45 0.39
Interest Cover(x) 1.37 -0.57 1.09 1.42 1.32 1.09 1.54 13.08 1.58 -3.23 0.52
Total Debt/Mcap(x) 2.72 1.98 1.57 4.93 3.06 3.73 2.14 0.69 2.33 2.75 1.63

Natraj Proteins Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 43.8 43.68 43.25 42.63 42.23 42.16 42.16 42.14 41.82 41.82
FII 0 0 0 0 0 0 0 0 0 0
DII 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.9
Public 54.27 54.39 54.82 55.44 55.84 55.91 55.91 55.93 56.25 56.28
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Natraj Proteins News

Natraj Proteins Pros & Cons

Pros

  • Stock is trading at 0.4 times its book value
  • Debtor days have improved from 7.79 to 4.95days.

Cons

  • Promoter holding is low: 41.82%.
  • Company has a low return on equity of -11% over the last 3 years.
whatsapp